Submit Manuscript  

Article Details


Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study

[ Vol. 20 , Issue. 9 ]

Author(s):

Konrad Dziobek*, Marcin Opławski, Beniamin Grabarek, Nikola Zmarzły, Robert Kiełbasiński, Ewa Leśniak, Piotr Januszyk, Krzysztof Januszyk, Iwona Adwent, Dariusz Dąbruś, Przemysław Kieszkowski, Kamil Kiełbasiński, Agnieszka Kuś-Kierach and Dariusz Boroń   Pages 727 - 732 ( 6 )

Abstract:


Background: In the course of neoplastic diseases, a reduction in SEMA3F expression is observed, which translates into an increase in the proliferative and proangiogenic potential of cells forming the tumor and the surrounding microenvironment.

Objective: The aim of this study was to determine the changes in SEMA3F level in endometrial cancer depending on its grade.

Methods: The study material consisted of tissue samples: 15 without neoplastic changes (control group) and 45 with endometrial cancer (G1, 17; G2, 15; G3, 13; study group). SEMA3F expression was assessed using the immunohistochemical method.

Results: The expression of SEMA3F was observed in the control group (Me = 159.38) and in the study group (G1, Me = 121.32; G2, Me = 0; G3, Me = 130.37). Differences between each grade and control and between individual grades were statistically significant. There were no significant correlations between SEMA3F expression and weight and Body Mass Index (BMI). The reduced SEMA3F expression in tumor tissue compared to healthy tissue indicates that this protein plays key roles in proliferation and angiogenesis.

Conclusion: We found that depending on the severity of the disease, cancer adopts different survival strategies, where SEMA3F plays an important role. As a molecular marker, SEMA3F is not sensitive to weight and BMI.

Keywords:

SEMA3F, endometrial cancer, angiogenesis, epigenetics, supplementary molecular marker, proliferation.

Affiliation:

Center of Oncology, M. Sklodowska-Curie Memorial Institute, Cracow Branch, Cracow, Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, Kraków, Department of Molecular Biology, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia in Katowice, Katowice, Department of Molecular Biology, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia in Katowice, Katowice, Department of Obstetrics & Gynaecology ward, Health Center in Mikołów, Mikołów, Department of Obstetrics & Gynaecology ward, Health Center in Mikołów, Mikołów, Faculty of Health Science, Public Higher Medical Professional School in Opole, Opole, Faculty of Health Science, Public Higher Medical Professional School in Opole, Opole, Faculty of Health Science, Public Higher Medical Professional School in Opole, Opole, Faculty of Health Science, Public Higher Medical Professional School in Opole, Opole, Voivodeship Specialist Hospital in Wloclawek, Włocławek, Pavol Jozef Šafárik University in Košice, Košice, Faculty of Health Science, Public Higher Medical Professional School in Opole, Opole, Center of Oncology, M. Sklodowska-Curie Memorial Institute, Cracow Branch, Cracow



Read Full-Text article